Monday, June 8, 2026

North Korea’s Response to the U.S. Secretary of State Visiting South Korea: Fire Ballistic Missiles Into the Sea

North Korea fired several ballistic missiles into...

Coupang Becomes A Trade Flashpoint as the United States Pressures Alarms Korean Lawmakers

The U.S. is using Coupang as leverage against South Korea, raising concerns in the National Assembly about trade implications.

Daegu Mayor’s Challenge: ‘Fight Like a Warrior or Perish’

On the 16th, Daegu Mayor Hong Joon...

Yu Ri Cho

Author's Latest

GI-101A: Breakthrough Immuno-Oncology Drug Set for ASCO 2026 Presentation

GI Innovation's GI-101A will be presented at ASCO 2026, highlighting its clinical potential and significance in oncology.

Top 3 Innovative Korean Biotech Firms Shine at Novo Nordisk Partnering Day 2026

Novo Nordisk Korea hosted Partnering Day 2026 to foster global partnerships in healthcare, highlighting innovative local biotech firms.

Over Half of Top Propofol-Using Clinics in Asia Found Violating Drug Control Law

Authorities found widespread narcotics violations in medical institutions using propofol, with over half inspected breaching regulations.

How ExcelOs Inject Revolutionizes Bone Grafting: Insights from the Latest GBR Seminar

CGBIO hosted a hands-on seminar for dental professionals, focusing on practical skills in maxillary sinus lifts and bone grafting techniques.

A Future Of 24/7 Health Monitoring: Korea Pushes AI-Driven Care Forward

Daewoong Pharmaceutical showcases its digital healthcare innovations, achieving significant market share with AI solutions for patient care.

2026 Digital Healthcare Revolution: How Daewoong Pharmaceutical and Puzzle AI are Automating Medical Records

Daewoong Pharmaceutical's Innovare Partners Day showcased AI in healthcare, featuring voice-based EMR and innovations in brain health.

LG Chem’s FMC-220: A Breakthrough Cancer Drug Targeting the p53 Y220C Mutation

LG Chem secures exclusive rights to FMC-220, a cancer drug targeting the p53 Y220C mutation, aiming for Phase 1 trials.

AITRICS Achieves MDSAP Certification: What This Means for Global Medical Device Standards

AITRICS gains MDSAP certification, enhancing its global market entry and demonstrating compliance with international quality standards.

KIMES 2026: Record-Breaking Medical Expo Achieves 2.3 Trillion USD in Domestic Deals!

KIMES 2026 set attendance records with 75,003 visitors, generating 1.5 billion USD in domestic consultations and 450 million USD in exports.

Classys Unveils Aggressive Growth Strategy at AAD 2026: What’s Next for the U.S. Market?

Classys reveals its growth strategy for the U.S. market at AAD 2026, showcasing innovative products and emphasizing clinical efficacy.

Rokit Healthcare’s Groundbreaking Kidney Regeneration Patent: What It Means for Patients and the Market

Rokit Healthcare secures a U.S. patent for kidney regeneration, aiming to revolutionize treatment and collaboration with Harvard Medical School.

New Class 4 Disease Regulations on Candida Auris Starting March 29 in South Korea

KDCA classifies Candida auris as a Class 4 infectious disease, enhancing surveillance and management to combat this resistant pathogen.

How the Late Lee Kun-hee’s 700 Billion Won Donation is Transforming Infectious Disease Research in Korea

The KDCA will host two international symposia on infectious disease research to enhance collaboration and response capabilities starting March 26.

Classys Global Customer Summit 2026: Insights from 500 Medical Professionals Across 20 Countries

Classys successfully hosted its Global Customer Summit 2026, showcasing innovative medical devices and attracting over 500 professionals globally.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.